Dr. Amy L. Ingram, MD

Dr. Ingram practices at Advanced ENT and Allergy in Louisville, Kentucky.

Dr. Ingram's NPI, 1588894653, was assigned on July 22, 2009. Dr. Ingram graduated from Southern Illinois University School of Medicine in 2014. Dr. Ingram holds Kentucky license 47054.

Dr. Ingram's primary practice is Advanced ENT and Allergy, at 9880 Angies Way, Louisville, KY 40241 in Jefferson County. The practice phone is (502) 893-0159.

Dr. Ingram's primary practice is Advanced ENT and Allergy in Louisville, Kentucky. Dr. Ingram is also affiliated with Norton Hospital. The medical group on file is Advanced ENT & Allergy. Dmand AI also links Dr. Ingram to 4 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingram practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Ingram's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Ingram's licenses on file in 2 states: Kentucky and Illinois.

CMS data shows 1,840 Medicare services from Dr. Ingram across 14 procedure codes in 2024, for 546 Medicare patients. Medicare paid $73,658 for them. Every service was in an office.

CMS counts 546 Medicare patients who saw Dr. Ingram in 2024. The largest group is 65 to 74, with 278 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ingram's median patient age at 55, with 60% women.

In 2024, Dr. Ingram wrote 804 Medicare Part D claims for 327 patients. 92% of them were for generic drugs. CMS names the drug for 667 of them, across 18 drugs with 11 or more claims each, at $14,442 in total drug cost. In 2023, CMS named 706 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Ingram for performance year 2024, reported as part of a group. Dr. Ingram accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Ingram, published from 2020 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Iontophoresis, Lidocaine and Middle Ear Ventilation. Dr. Ingram's most frequent co-authors are John P. Gavin, MD, Susannah Eldridge Hills, MD and Lawrence R. Lustig, MD.

Dmand AI links Dr. Ingram to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Otomycosis, Mycoses and Tinnitus. Hill Dermaceuticals, Inc. sponsors the most, 2.

CMS Open Payments shows 213 general payments to Dr. Ingram from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Smith & Nephew, Inc. paid the most, $2,224.

Dr. Ingram graduated from Southern Illinois University School of Medicine in 2014.